CHIMICA E FARMACEUTICA

GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged 12 through 17. The approval follows the positive recommendation made by the European M...

I dati nel report EGUALIA relativo ai trend 2021. Al Nord i consumi più elevati e la minore spesa per i cittadini, che pagano ancora di tasca loro oltre 1 miliardo per ritirare l’off patent di marca.

L’assetto normativo attuale crea una palese disparità di trattamento tra le diverse categorie di appalti, lasciando le aziende del settore sanitario prive di paracadute

SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.

Como, 16/06/2022 - I macchinari Steriline simboleggiano il contributo apportato dall’industria italiana alla lotta contro il Covid, con specifico riferimento ai processi di distribuzione e di somministrazione dei vaccini nel mondo. I sofisticatissimi sistemi di riempimento per farmaci iniettabili progettati e prodotti dalla nota azienda comasca, hanno infatti contribuito attivamente all’applicazione delle campagne vaccinali su scala internazionale.

Il progetto promuove una maggiore responsabilità nella popolazione, coinvolgendo pazienti asintomatici per prevenite la diffusione di COVID-19

TOKYO, June 9, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., launched on May 30 a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry.

GAITHERSBURG, Md., June 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine (NVX-CoV2373) for individuals age...

ESTABLISHES A SINGULAR, LARGE-SCALE HIFI LONG READ SEQUENCING SERVICE FOR THE BIOPHARMACEUTICAL INDUSTRY

Partnership intends to accelerate translation of discoveries in disease biology towards novel treatments for patients with tauopathies.

Padova, 1 giugno 2022 - L'ingresso dei farmaci equivalenti nel mercato farmaceutico mondiale è un fenomeno di notevole interesse in termini economico-sociali, che dovrebbe aver modificato significativamente sia le strategie aziendali, sia i comportamenti di tutti gli attori coinvolti nella filiera assistenziale.

NEWARK, Delaware, 1 giugno 2022 /PRNewswire/ -- Covation Biomaterials, azienda leader a livello mondiale che offre soluzioni a base biologica, è stata lanciata oggi come attività indipendente, in seguito all'acquisizione di DuPont Biomaterials da parte del Gruppo Huafon. 

Investment and expansion plans position Repeats as a leader in low-density polyethylene recycling in Europe

HOUSTON, June 1, 2022 /PRNewswire/ -- Ascend Performance Materials has completed its purchase of Formulated Polymers Limited, an engineered materials producer based in Chennai, India. The acquisition establishes Ascend's first production facility in South Asia.

SINGAPORE, May 31, 2022 /PRNewswire/ -- Nalagenetics has just completed CE-marking for one of the reporting modules of its Clinical Decision Support (CDS) software.

GENEVA, May 30, 2022 /PRNewswire/ -- The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted "breakthrough device designation" by the FDA on March 4, 2019 and further in September 25, 2019 for below-the-knee (BTK) indications in peripheral artery disease.

- WDHD 2022 is dedicated to raising awareness on colorectal cancer prevention